Cargando…
Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes
OBJECTIVE: To assess the prevalence of and trends in complications among U.S. adults with newly diagnosed diabetes. RESEARCH DESIGN AND METHODS: We included 1,486 nonpregnant adults (aged ≥20 years) with newly diagnosed diabetes (diagnosed within the past 2 years) from the 1988–1994 and 1999–2018 Na...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896270/ https://www.ncbi.nlm.nih.gov/pubmed/33419932 http://dx.doi.org/10.2337/dc20-2304 |
_version_ | 1783653520084303872 |
---|---|
author | Fang, Michael Selvin, Elizabeth |
author_facet | Fang, Michael Selvin, Elizabeth |
author_sort | Fang, Michael |
collection | PubMed |
description | OBJECTIVE: To assess the prevalence of and trends in complications among U.S. adults with newly diagnosed diabetes. RESEARCH DESIGN AND METHODS: We included 1,486 nonpregnant adults (aged ≥20 years) with newly diagnosed diabetes (diagnosed within the past 2 years) from the 1988–1994 and 1999–2018 National Health and Nutrition Examination Survey. We estimated trends in albuminuria (albumin-to-creatinine ratio ≥30 mg/g), reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m(2)), retinopathy (any retinal microaneurysms or blot hemorrhages), and self-reported cardiovascular disease (history of congestive heart failure, heart attack, or stroke). RESULTS: From 1988–1994 to 2011–2018, there was a significant decrease in the prevalence of albuminuria (38.9 to 18.7%, P for trend <0.001) but no change in the prevalence of reduced eGFR (7.5 to 9.9%, P for trend = 0.30), retinopathy (1988–1994 to 1999–2008 only; 13.2 to 12.1%, P for trend = 0.86), or self-reported cardiovascular disease (19.0 to 16.5%, P for trend = 0.64). There were improvements in glycemic, blood pressure, and lipid control in the population, and these partially explained the decline in albuminuria. Complications were more common at the time of diabetes diagnosis for adults who were older, lower income, less educated, and obese. CONCLUSIONS: Over the past three decades, there have been encouraging reductions in albuminuria and risk factor control in adults with newly diagnosed diabetes. However, the overall burden of complications around the time of the diagnosis remains high. |
format | Online Article Text |
id | pubmed-7896270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-78962702022-03-01 Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes Fang, Michael Selvin, Elizabeth Diabetes Care Epidemiology/Health Services Research OBJECTIVE: To assess the prevalence of and trends in complications among U.S. adults with newly diagnosed diabetes. RESEARCH DESIGN AND METHODS: We included 1,486 nonpregnant adults (aged ≥20 years) with newly diagnosed diabetes (diagnosed within the past 2 years) from the 1988–1994 and 1999–2018 National Health and Nutrition Examination Survey. We estimated trends in albuminuria (albumin-to-creatinine ratio ≥30 mg/g), reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m(2)), retinopathy (any retinal microaneurysms or blot hemorrhages), and self-reported cardiovascular disease (history of congestive heart failure, heart attack, or stroke). RESULTS: From 1988–1994 to 2011–2018, there was a significant decrease in the prevalence of albuminuria (38.9 to 18.7%, P for trend <0.001) but no change in the prevalence of reduced eGFR (7.5 to 9.9%, P for trend = 0.30), retinopathy (1988–1994 to 1999–2008 only; 13.2 to 12.1%, P for trend = 0.86), or self-reported cardiovascular disease (19.0 to 16.5%, P for trend = 0.64). There were improvements in glycemic, blood pressure, and lipid control in the population, and these partially explained the decline in albuminuria. Complications were more common at the time of diabetes diagnosis for adults who were older, lower income, less educated, and obese. CONCLUSIONS: Over the past three decades, there have been encouraging reductions in albuminuria and risk factor control in adults with newly diagnosed diabetes. However, the overall burden of complications around the time of the diagnosis remains high. American Diabetes Association 2021-03 2021-01-08 /pmc/articles/PMC7896270/ /pubmed/33419932 http://dx.doi.org/10.2337/dc20-2304 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
spellingShingle | Epidemiology/Health Services Research Fang, Michael Selvin, Elizabeth Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes |
title | Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes |
title_full | Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes |
title_fullStr | Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes |
title_full_unstemmed | Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes |
title_short | Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes |
title_sort | thirty-year trends in complications in u.s. adults with newly diagnosed type 2 diabetes |
topic | Epidemiology/Health Services Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896270/ https://www.ncbi.nlm.nih.gov/pubmed/33419932 http://dx.doi.org/10.2337/dc20-2304 |
work_keys_str_mv | AT fangmichael thirtyyeartrendsincomplicationsinusadultswithnewlydiagnosedtype2diabetes AT selvinelizabeth thirtyyeartrendsincomplicationsinusadultswithnewlydiagnosedtype2diabetes |